Alan Cooke serves as Chief Executive Officer, President and Member of the Board of Directors. Prior to Sebela Pharmaceuticals, Alan held a number of executive-level positions in pharmaceuticals and medical devices, including Chief Financial Officer and subsequently Chief Executive Officer of Trulife Group Limited; Chief Financial Officer and subsequently President and Chief Operating Officer of Amarin Corporation, plc; and Vice President, Global Strategic Planning of Elan Corporation, plc. Prior to Elan, Alan worked at KPMG and is a fellow of the Institute of Chartered Accountants (Ireland). Alan also served as Chairman of the Board of the Institute of Neuroscience at Trinity College Dublin. Alan is a Director of DS Biopharma Limited and Afimmune Limited.